Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
10
Métodos estadísticos
7
Ensayos clínicos
6
Investigaciones
6
Metodología
6
Pruebas clínicas
5
Práctica de juicios
5
Blues (Música)
3
Cáncer
3
Ensayos clinicos
3
Administración de justicia
2
Asesinato
2
Biografía
2
Civilización
2
Delitos políticos
2
Derecho
2
Diseño de investigación
2
Estados Unidos
2
Estadística
2
Evolución (Biología)
2
Libretos para óperas
2
Literatura inglesa
2
Medicina
2
Novela alemana
2
Novela estadounidense
2
Novela inglesa
2
Oncología
2
Orientación profesional
2
Política y gobierno
2
Quimioterapia
2
-
343801por Rose, April A N, Armstrong, Susan M, Hogg, David, Butler, Marcus O, Saibil, Samuel D, Arteaga, Diana P, Pimentel Muniz, Thiago, Kelly, Deirdre, Ghazarian, Danny, King, Ian, Kamil, Zaid Saeed, Ross, Kendra, Spreafico, Anna“…Primary tumor type and genomic subtype—including NRAS—should be further evaluated in prospective clinical trials to determine their value as predictive markers. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343802por Price, Christina C., Altice, Frederick L., Shyr, Yu, Koff, Alan, Pischel, Lauren, Goshua, George, Azar, Marwan M., Mcmanus, Dayna, Chen, Sheau-Chiann, Gleeson, Shana E., Britto, Clemente J., Azmy, Veronica, Kaman, Kelsey, Gaston, David C., Davis, Matthew, Burrello, Trisha, Harris, Zachary, Villanueva, Merceditas S., Aoun-Barakat, Lydia, Kang, Insoo, Seropian, Stuart, Chupp, Geoffrey, Bucala, Richard, Kaminski, Naftali, Lee, Alfred I., LoRusso, Patricia Mucci, Topal, Jeffrey E., Dela Cruz, Charles, Malinis, Maricar“…In tocilizumab-treated patients, oxygenation and inflammatory biomarkers improved, with higher than expected survival. Randomized trials must confirm these findings.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343803por Laviola, Luigi, Porcellati, Francesca, Bruttomesso, Daniela, Larosa, Monica, Rossi, Maria Chiara, Nicolucci, Antonio“…INTRODUCTION: Following pivotal trials, real-world evidence is important to assess the impact of new drugs in everyday clinical practice. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343804por Pierce, Stuart R., Fang, Ziwei, Yin, Yajie, West, Lindsay, Asher, Majdouline, Hao, Tianran, Zhang, Xin, Tucker, Katherine, Staley, Allison, Fan, Yali, Sun, Wenchuan, Moore, Dominic T., Xu, Chang, Tsai, Yi-Hsuan, Parker, Joel, Prabhu, Varun Vijay, Allen, Joshua E., Lee, Douglas, Zhou, Chunxiao, Bae-Jump, Victoria“…BACKGROUND: ONC201 is a dopamine receptor D2 (DRD2) antagonist that inhibits tumor growth in preclinical models through ClpP activation to induce integrated stress response pathway and mitochondrial events related to inhibition of cell growth, which is being explored in clinical trials for solid tumors and hematological malignancies. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343805por Huang, Chi-Cheng, Tsai, Yi-Fang, Liu, Chun-Yu, Chao, Ta-Chung, Lien, Pei-Ju, Lin, Yen-Shu, Feng, Chin-Jung, Chiu, Jen-Hwey, Hsu, Chih-Yi, Tseng, Ling-Ming“…RESULTS: A total of 380 TMO comprehensive assays were conducted on 372 patients, and we presented targeted sequencing analyses of Tier I: alteration-drug match associated with improved outcome in clinical trials including ERBB2 amplification, BRCA1/2 germline mutation, PIK3CA mutation, and NTRK translocation, and Tier II: antitumor activity associated with the matched alteration-drug but lack of prospective outcome data including PTEN loss, ESR1 mutation, AKT1 mutation, and ERBB2 mutation, and Tier III: matched drug-alteration that led to clinical benefit in another tumor type including MDM2 amplification, and ERBB3 mutation. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343806por Bongomin, Felix, Olum, Ronald, Kyazze, Andrew Peter, Ninsiima, Sandra, Nattabi, Gloria, Nakyagaba, Lourita, Nabakka, Winnie, Kukunda, Rebecca, Ssekamatte, Phillip, Kibirige, Davis, Cose, Stephen, Nakimuli, Annettee, Baluku, Joseph Baruch, Andia-Biraro, Irene“…We also performed a systematic review (PROSPERO Registration ID: CRD42020213001) and meta-analysis of studies indexed on MEDLINE, Embase, African Journal Online, ClinicalTrials.gov, ICTRP, and the Cochrane Library of systematic review between 1 January 2000 and 31 September 2020 reporting on the prevalence of anemia in pregnancy in Uganda. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343807por Goel, Rishi R., Apostolidis, Sokratis A., Painter, Mark M., Mathew, Divij, Pattekar, Ajinkya, Kuthuru, Oliva, Gouma, Sigrid, Kuri-Cervantes, Leticia, Meng, Wenzhao, Adamski, Sharon, Baxter, Amy E., Giles, Josephine R., Weirick, Madison E., McAllister, Christopher M., Hicks, Amanda, Korte, Scott, Dougherty, Jeanette, Long, Sherea, D’Andrea, Kurt, Hamilton, Jacob T., Prak, Eline T Luning, Betts, Michael R., Bates, Paul, Hensley, Scott E., Greenplate, Allison R., Wherry, E. John“…Despite their efficacy in clinical trials, there is limited data on vaccine-induced immune responses in individuals with a prior SARS-CoV2 infection compared to SARS-CoV2 naïve subjects. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343808por Shirvani, Tayebeh, Javadivala, Zeinab, Azimi, Somayeh, Shaghaghi, Abdolreza, Fathifar, Zahra, Devender Bhalla, H. D. R., Abdekhoda, Mohammadhiwa, Nadrian, Haidar“…The incidence rate of T2D was reported in three trials, within which the risk of developing T2D was reduced by 54.0% in favor of community-based educational interventions, (RR = 0.54, 95% CI = 0.38–0.75; p < 0.001). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343809por Caparrotta, Thomas M., Greenhalgh, Andrew M., Osinski, Karen, Gifford, Robert M., Moser, Svenja, Wild, Sarah H., Reynolds, Rebecca M., Webb, David J., Colhoun, Helen M.“…They have been shown to be safe (from the cardiovascular (CV) perspective) and effective (in terms of glycaemia, and in some cases, in reducing CV events) in extensive randomised controlled trials (RCTs). However, there remain concerns regarding the generalisability of these findings (to those ineligible for RCT participation) and about non-CV safety. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343810por Caparrotta, Thomas M., Templeton, Jack B., Clay, Thomas A., Wild, Sarah H., Reynolds, Rebecca M., Webb, David J., Colhoun, Helen M.“…They have been shown to be safe (from the cardiovascular (CV) perspective) and effective (in terms of glycaemia, and in some cases, reducing CV events) in extensive randomised controlled trials (RCTs). However, there remain concerns regarding the generalisability of these findings (to those ineligible for RCT participation) and about non-CV safety. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343811por Bargar, Connor, Wang, Wen, Gunzler, Steven A., LeFevre, Alexandra, Wang, Zerui, Lerner, Alan J., Singh, Neena, Tatsuoka, Curtis, Appleby, Brian, Zhu, Xiongwei, Xu, Rong, Haroutunian, Vahram, Zou, Wen-Quan, Ma, Jiyan, Chen, Shu G.“…The ongoing evaluation of RT-QuIC assay of αSyn(D) as a potential biomarker for PD and DLB in clinically accessible biospecimens has broad implications for understanding disease pathogenesis, improving early and differential diagnosis, and monitoring therapeutic efficacies in clinical trials.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343812por Zhang, Xiaoqin, Wang, Ziyue, Zeng, Zixin, Shen, Ningning, Wang, Bin, Zhang, Yaping, Shen, Honghong, Lu, Wei, Wei, Rong, Ma, Wenxia, Wang, Chen“…However, more detailed experiments and clinical trials are needed to support its potential drug-target role in clinical medical use. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343813por Padhiar, Nat, Curtin, Mark, Aweid, Osama, Aweid, Bashaar, Morrissey, Dylan, Chan, Otto, Malliaras, Peter, Crisp, Tom“…This benefit may be maintained long-term; however, more robust trials are required to validate these findings in the absence of controls. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343814por Chastin, Sebastien F. M., Abaraogu, Ukachukwu, Bourgois, Jan G., Dall, Philippa M., Darnborough, Jennifer, Duncan, Elaine, Dumortier, Jasmien, Pavón, David Jiménez, McParland, Joanna, Roberts, Nicola J., Hamer, Mark“…We searched seven databases (MEDLINE, Embase, Cochrane CENTRAL, Web of Science, CINAHL, PsycINFO, and SportDiscus) up to April 2020 for randomised controlled trials and prospective observational studies were included if they compared groups of adults with different levels of physical activity and reported immune system cell count, the concentration of antibody, risk of clinically diagnosed infections, risk of hospitalisation and mortality due to infectious disease. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343815por Lavinio, Andrea, Ercole, Ari, Battaglini, Denise, Magnoni, Sandra, Badenes, Rafael, Taccone, Fabio Silvio, Helbok, Raimund, Thomas, William, Pelosi, Paolo, Robba, Chiara“…Whilst full anticoagulation has been questioned for prophylaxis in these patients, our results suggest that there may nevertheless be a role for enhanced / intermediate levels of prophylaxis. Clinical trials investigating causal relationship between intermediate thromboprophylaxis and clinical outcomes are urgently needed. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343816por Lontchi-Yimagou, Eric, Feutseu, Charly, Kenmoe, Sebastien, Djomkam Zune, Alexandra Lindsey, Kinyuy Ekali, Solange Fai, Nguewa, Jean Louis, Choukem, Siméon Pierre, Mbanya, Jean Claude, Gautier, Jean Francois, Sobngwi, Eugene“…We searched PubMed, Embase, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, and Web of Science with no language restriction, to identify articles published until February 15, 2021. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343817por Lorenzatti, Alberto J., Monsalvo, Maria Laura, López, J. Antonio G., Wang, Huei, Rosenson, Robert S.“…METHODS: This post-hoc analysis combined data from two randomized, placebo-controlled trials, BANTING and BERSON, to investigate the effect of evolocumab (140 mg every two weeks [Q2W] or 420 mg monthly [QM]) on atherogenic lipid (LDL-C, non-HDL-C, VLDL-C, remnant cholesterol) and lipoproteins (ApoB, lipoprotein(a) (Lp[a])), and achievement of 2019 European Society of Cardiology/European Atherosclerosis Society lipid treatment goals in individuals with and without AD. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343818por Ma, Jianglei, Li, Xiaoyao, Zhao, Shifu, Wang, Jiawei, Zhang, Wujia, Sun, Guangyuan“…Moreover, more randomized controlled trials comparing the two techniques with rigorous study designs are still essential to evaluate the value of robotic surgery for NSCLC. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343819“…We conducted a systematic search of randomized controlled trials, cohort, and cross-sectional studies done in sub-Saharan African countries and published from 2004 to 2020. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343820por Wirtz, Andrea L, Cooney, Erin E, Stevenson, Megan, Radix, Asa, Poteat, Tonia, Wawrzyniak, Andrew J, Cannon, Christopher M, Schneider, Jason S, Haw, J Sonya, Case, James, Althoff, Keri N, Humes, Elizabeth, Mayer, Kenneth H, Beyrer, Chris, Rodriguez, Allan E, Reisner, Sari L“…Cohort studies identify unique risks for affected populations, but use of facility-based methods may bias findings towards individuals living in research catchment areas, more engaged in health services, or, in the case of transgender populations, those who are open about their transgender identity. Digital clinical trials and other online research methods are increasingly common, providing opportunity to reach those not commonly engaged in research. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto